Resapp Health

Resapp Health EV/Revenue

The EV/Revenue (Enterprise Value to Revenue) of Resapp Health (RAP.AX) as of Oct 19, 2026 is 12.01. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 374.87 — a change of -96.80% (lower).

EV/Revenue

12.01

YoY

-96.80%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of Resapp Health is 2022 12.01 . EV/Revenue (Enterprise Value to Revenue) of Resapp Health was 2021 374.87 . It decreases by -96.80% lower compared to the previous year.

The Resapp Health EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2021
374.87 AUD
Jan 1, 2022
12.01 AUD
The Resapp Health EV/Revenue history
YEAREV/RevenueYoY
12.01-96.80%
374.87—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Resapp Health Stock analysis

What does Resapp Health do? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Resapp Health stock

EV/Revenue (Enterprise Value to Revenue) of Resapp Health is 12.01 in 2022.

EV/Revenue (Enterprise Value to Revenue) of Resapp Health changed from 374.87 to 12.01, representing a -96.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) Resapp Health since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s Resapp Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Resapp Health

All Key Metrics — Resapp Health